药品名称NASALIDE
申请号018148产品号001
活性成分FLUNISOLIDE市场状态停止上市
剂型或给药途径SPRAY, METERED;NASAL规格0.025MG/SPRAY
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构IVAX RESEARCH INC
化学类型New molecular entity (NME)审评分类Priority review drug
与本品相关的专利信息(来自橙皮书Orange Book)
专利号专利过期日是否化合物专利是否产品专利专利用途代码专利下载
历史专利信息
49331682007/06/12PDF格式
与本品相关的市场独占权保护信息
独占权代码失效日期
历史市场独占权保护信息
与药品注册相关的信息
申请号修订号审批结论公开文档类型文档创建时间获取文档
018148035APLetter2002/05/09下载
018148030APLetter2002/05/09下载
018148023APReview1999/02/25下载
药品注册审批历史信息
申请号修订号审批结论审批日期审批内容
018148037AP2002/08/23Control Supplement
018148035AP2002/05/09Labeling Revision
018148033AP2000/09/13Manufacturing Change or Addition
018148032AP2000/06/29Manufacturing Change or Addition
018148030AP2002/05/09Labeling Revision
018148029AP1999/02/05Control Supplement
018148028AP1998/04/21Control Supplement
018148027AP1996/08/02Manufacturing Change or Addition
018148025AP1994/08/05Control Supplement
018148024AP1994/08/17Control Supplement
018148023AP1999/02/25New Dosage Regimen
018148022AP1989/03/07Package Change
018148021AP1989/02/08Labeling Revision
018148020AP1987/12/23Control Supplement
018148015AP1986/09/19Labeling Revision
018148014AP1989/08/25Manufacturing Change or Addition
018148013AP1985/07/11Labeling Revision
018148012AP1985/09/23Labeling Revision
018148011AP1986/08/19Control Supplement
018148010AP1984/03/13Labeling Revision
018148008AP1985/02/21Control Supplement
018148007AP1986/04/21Formulation Revision
018148006AP1983/06/22Labeling Revision
018148005AP1983/09/09Manufacturing Change or Addition
018148004AP1983/09/09Manufacturing Change or Addition
018148003AP1983/09/09Manufacturing Change or Addition
018148002AP1983/09/09Manufacturing Change or Addition
018148001AP1983/08/30Labeling Revision
018148000AP1981/09/24Approval